Copyright Reports & Markets. All rights reserved.

Global Hepatitis A immunoglobulin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hepatitis A immunoglobulin Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Inactivated
    • 1.3.3 Attenuated
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hepatitis A immunoglobulin Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
    • 1.4.4 Other
  • 1.5 Global Hepatitis A immunoglobulin Market Size & Forecast
    • 1.5.1 Global Hepatitis A immunoglobulin Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Hepatitis A immunoglobulin Sales Quantity (2020-2031)
    • 1.5.3 Global Hepatitis A immunoglobulin Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 CSL Behring
    • 2.1.1 CSL Behring Details
    • 2.1.2 CSL Behring Major Business
    • 2.1.3 CSL Behring Hepatitis A immunoglobulin Product and Services
    • 2.1.4 CSL Behring Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 CSL Behring Recent Developments/Updates
  • 2.2 AIM Vaccine
    • 2.2.1 AIM Vaccine Details
    • 2.2.2 AIM Vaccine Major Business
    • 2.2.3 AIM Vaccine Hepatitis A immunoglobulin Product and Services
    • 2.2.4 AIM Vaccine Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 AIM Vaccine Recent Developments/Updates
  • 2.3 Sinovac Biotech
    • 2.3.1 Sinovac Biotech Details
    • 2.3.2 Sinovac Biotech Major Business
    • 2.3.3 Sinovac Biotech Hepatitis A immunoglobulin Product and Services
    • 2.3.4 Sinovac Biotech Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sinovac Biotech Recent Developments/Updates
  • 2.4 Pukang Biotechnology
    • 2.4.1 Pukang Biotechnology Details
    • 2.4.2 Pukang Biotechnology Major Business
    • 2.4.3 Pukang Biotechnology Hepatitis A immunoglobulin Product and Services
    • 2.4.4 Pukang Biotechnology Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Pukang Biotechnology Recent Developments/Updates
  • 2.5 Zhifei Biological Products
    • 2.5.1 Zhifei Biological Products Details
    • 2.5.2 Zhifei Biological Products Major Business
    • 2.5.3 Zhifei Biological Products Hepatitis A immunoglobulin Product and Services
    • 2.5.4 Zhifei Biological Products Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Zhifei Biological Products Recent Developments/Updates
  • 2.6 Changchun Lnstitute Of Biological Products
    • 2.6.1 Changchun Lnstitute Of Biological Products Details
    • 2.6.2 Changchun Lnstitute Of Biological Products Major Business
    • 2.6.3 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product and Services
    • 2.6.4 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Changchun Lnstitute Of Biological Products Recent Developments/Updates
  • 2.7 Native Antigen
    • 2.7.1 Native Antigen Details
    • 2.7.2 Native Antigen Major Business
    • 2.7.3 Native Antigen Hepatitis A immunoglobulin Product and Services
    • 2.7.4 Native Antigen Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Native Antigen Recent Developments/Updates
  • 2.8 GSK
    • 2.8.1 GSK Details
    • 2.8.2 GSK Major Business
    • 2.8.3 GSK Hepatitis A immunoglobulin Product and Services
    • 2.8.4 GSK Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 GSK Recent Developments/Updates
  • 2.9 Merck
    • 2.9.1 Merck Details
    • 2.9.2 Merck Major Business
    • 2.9.3 Merck Hepatitis A immunoglobulin Product and Services
    • 2.9.4 Merck Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Merck Recent Developments/Updates
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Hepatitis A immunoglobulin Product and Services
    • 2.10.4 Sanofi Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Sanofi Recent Developments/Updates
  • 2.11 Dr. Reddy's Laboratories
    • 2.11.1 Dr. Reddy's Laboratories Details
    • 2.11.2 Dr. Reddy's Laboratories Major Business
    • 2.11.3 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product and Services
    • 2.11.4 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Dr. Reddy's Laboratories Recent Developments/Updates

3 Competitive Environment: Hepatitis A immunoglobulin by Manufacturer

  • 3.1 Global Hepatitis A immunoglobulin Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Hepatitis A immunoglobulin Revenue by Manufacturer (2020-2025)
  • 3.3 Global Hepatitis A immunoglobulin Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Hepatitis A immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Hepatitis A immunoglobulin Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Hepatitis A immunoglobulin Manufacturer Market Share in 2024
  • 3.5 Hepatitis A immunoglobulin Market: Overall Company Footprint Analysis
    • 3.5.1 Hepatitis A immunoglobulin Market: Region Footprint
    • 3.5.2 Hepatitis A immunoglobulin Market: Company Product Type Footprint
    • 3.5.3 Hepatitis A immunoglobulin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hepatitis A immunoglobulin Market Size by Region
    • 4.1.1 Global Hepatitis A immunoglobulin Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Hepatitis A immunoglobulin Consumption Value by Region (2020-2031)
    • 4.1.3 Global Hepatitis A immunoglobulin Average Price by Region (2020-2031)
  • 4.2 North America Hepatitis A immunoglobulin Consumption Value (2020-2031)
  • 4.3 Europe Hepatitis A immunoglobulin Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Hepatitis A immunoglobulin Consumption Value (2020-2031)
  • 4.5 South America Hepatitis A immunoglobulin Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Hepatitis A immunoglobulin Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Hepatitis A immunoglobulin Sales Quantity by Type (2020-2031)
  • 5.2 Global Hepatitis A immunoglobulin Consumption Value by Type (2020-2031)
  • 5.3 Global Hepatitis A immunoglobulin Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Hepatitis A immunoglobulin Sales Quantity by Application (2020-2031)
  • 6.2 Global Hepatitis A immunoglobulin Consumption Value by Application (2020-2031)
  • 6.3 Global Hepatitis A immunoglobulin Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Hepatitis A immunoglobulin Sales Quantity by Type (2020-2031)
  • 7.2 North America Hepatitis A immunoglobulin Sales Quantity by Application (2020-2031)
  • 7.3 North America Hepatitis A immunoglobulin Market Size by Country
    • 7.3.1 North America Hepatitis A immunoglobulin Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Hepatitis A immunoglobulin Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Hepatitis A immunoglobulin Sales Quantity by Type (2020-2031)
  • 8.2 Europe Hepatitis A immunoglobulin Sales Quantity by Application (2020-2031)
  • 8.3 Europe Hepatitis A immunoglobulin Market Size by Country
    • 8.3.1 Europe Hepatitis A immunoglobulin Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Hepatitis A immunoglobulin Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hepatitis A immunoglobulin Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Hepatitis A immunoglobulin Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Hepatitis A immunoglobulin Market Size by Region
    • 9.3.1 Asia-Pacific Hepatitis A immunoglobulin Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Hepatitis A immunoglobulin Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Hepatitis A immunoglobulin Sales Quantity by Type (2020-2031)
  • 10.2 South America Hepatitis A immunoglobulin Sales Quantity by Application (2020-2031)
  • 10.3 South America Hepatitis A immunoglobulin Market Size by Country
    • 10.3.1 South America Hepatitis A immunoglobulin Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Hepatitis A immunoglobulin Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hepatitis A immunoglobulin Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Hepatitis A immunoglobulin Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Hepatitis A immunoglobulin Market Size by Country
    • 11.3.1 Middle East & Africa Hepatitis A immunoglobulin Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Hepatitis A immunoglobulin Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Hepatitis A immunoglobulin Market Drivers
  • 12.2 Hepatitis A immunoglobulin Market Restraints
  • 12.3 Hepatitis A immunoglobulin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hepatitis A immunoglobulin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hepatitis A immunoglobulin
  • 13.3 Hepatitis A immunoglobulin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hepatitis A immunoglobulin Typical Distributors
  • 14.3 Hepatitis A immunoglobulin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hepatitis A immunoglobulin market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Hepatitis A immunoglobulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hepatitis A immunoglobulin market size and forecasts, in consumption value ($ Million), sales quantity (Doses), and average selling prices (US$/Dose), 2020-2031
    Global Hepatitis A immunoglobulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Doses), and average selling prices (US$/Dose), 2020-2031
    Global Hepatitis A immunoglobulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Doses), and average selling prices (US$/Dose), 2020-2031
    Global Hepatitis A immunoglobulin market shares of main players, shipments in revenue ($ Million), sales quantity (Doses), and ASP (US$/Dose), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hepatitis A immunoglobulin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hepatitis A immunoglobulin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK, Merck, Sanofi, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hepatitis A immunoglobulin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Inactivated
    Attenuated
    Market segment by Application
    Hospital
    Pharmacy
    Other
    Major players covered
    CSL Behring
    AIM Vaccine
    Sinovac Biotech
    Pukang Biotechnology
    Zhifei Biological Products
    Changchun Lnstitute Of Biological Products
    Native Antigen
    GSK
    Merck
    Sanofi
    Dr. Reddy's Laboratories
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hepatitis A immunoglobulin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hepatitis A immunoglobulin, with price, sales quantity, revenue, and global market share of Hepatitis A immunoglobulin from 2020 to 2025.
    Chapter 3, the Hepatitis A immunoglobulin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hepatitis A immunoglobulin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hepatitis A immunoglobulin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatitis A immunoglobulin.
    Chapter 14 and 15, to describe Hepatitis A immunoglobulin sales channel, distributors, customers, research findings and conclusion.

    Buy now